Literature DB >> 9924027

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

H Miyoshi1, K A Smith, D E Mosier, I M Verma, B E Torbett.   

Abstract

Efficient gene transfer into human hematopoietic stem cells (HSCs) is an important goal in the study of the hematopoietic system as well as for gene therapy of hematopoietic disorders. A lentiviral vector based on the human immunodeficiency virus (HIV) was able to transduce human CD34+ cells capable of stable, long-term reconstitution of nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. High-efficiency transduction occurred in the absence of cytokine stimulation and resulted in transgene expression in multiple lineages of human hematopoietic cells for up to 22 weeks after transplantation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9924027     DOI: 10.1126/science.283.5402.682

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  113 in total

1.  A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.

Authors:  N Srinivasakumar; F G Schuening
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Cautious advance. Gene therapy is more complex than anticipated.

Authors:  A Fischer
Journal:  EMBO Rep       Date:  2000-10       Impact factor: 8.807

3.  Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro.

Authors:  I Hamaguchi; N B Woods; I Panagopoulos; E Andersson; H Mikkola; C Fahlman; R Zufferey; L Carlsson; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 4.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

Review 5.  Selective expansion of transduced cells for hematopoietic stem cell gene therapy.

Authors:  Akihiro Kume; Yutaka Hanazono; Hiroaki Mizukami; Takashi Okada; Keiya Ozawa
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

Review 6.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

Authors:  Sheng Zhou; Disha Mody; Suk See DeRavin; Julia Hauer; Taihe Lu; Zhijun Ma; Salima Hacein-Bey Abina; John T Gray; Michael R Greene; Marina Cavazzana-Calvo; Harry L Malech; Brian P Sorrentino
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

8.  Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells.

Authors:  H Mikkola; N B Woods; M Sjögren; H Helgadottir; I Hamaguchi; S E Jacobsen; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions.

Authors:  Koji Fujita; Yoshitaka Yamaguchi; Tsuyoshi Mori; Naomi Muramatsu; Takahito Miyamoto; Masashi Yano; Hironori Miyata; Akira Ootsuyama; Makoto Sawada; Haruo Matsuda; Ryuji Kaji; Suehiro Sakaguchi
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

Review 10.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.